top of page

A new treatment paradigm for migraine

We are a medical technology company developing and commercializing novel treatments based on the modulation of CO2 and oxygen in the central nervous system

PRODUCT

Our first product is the Rehaler, a medical device for the treatment of migraine with aura. 

Packshots_Cubecon_Combi_mobile_2.png

Rehaler – © 2024 / CVR: 41553456
Rehaler A/S, Vesterbrogade 149, B9, 1., 1620 Copenhagen V,  Denmark

Please note: Any recommendation given on this website cannot replace a healthcare professional’s direction or diagnosis. If you are unsure, please consult with your healthcare practitioner.

bottom of page